MCID: CRN019
MIFTS: 39

Coronary Artery Vasospasm

Categories: Cardiovascular diseases

Aliases & Classifications for Coronary Artery Vasospasm

MalaCards integrated aliases for Coronary Artery Vasospasm:

Name: Coronary Artery Vasospasm 12 14 69
Coronary Vasospasm 12 52 42
Coronary Artery Spasm 12 29

Classifications:



External Ids:

Disease Ontology 12 DOID:11840
MeSH 42 D003329
NCIt 47 C34515
SNOMED-CT 64 23687008
UMLS 69 C0010073

Summaries for Coronary Artery Vasospasm

MalaCards based summary : Coronary Artery Vasospasm, also known as coronary vasospasm, is related to myocardial infarction and progressive black carbon hyperpigmentation of infancy, and has symptoms including angina pectoris An important gene associated with Coronary Artery Vasospasm is EDN1 (Endothelin 1), and among its related pathways/superpathways are Calcium signaling pathway and HIF1Alpha Pathway. The drugs Simvastatin and Losartan have been mentioned in the context of this disorder. Affiliated tissues include endothelial, testes and bone, and related phenotype is muscle.

Wikipedia : 72 Coronary vasospasm is a sudden, intense vasoconstriction of an epicardial coronary artery that causes... more...

Related Diseases for Coronary Artery Vasospasm

Diseases related to Coronary Artery Vasospasm via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 54)
id Related Disease Score Top Affiliating Genes
1 myocardial infarction 28.8 EDN1 KNG1 NOS3 TNNI3
2 progressive black carbon hyperpigmentation of infancy 10.6 EDN1 NOS3
3 lethal congenital contractural syndrome 2 10.5 EDN1 NOS3
4 renovascular hypertension 10.5 EDN1 NOS3
5 aortopulmonary window 10.5 EDN1 NOS3
6 traumatic glaucoma 10.5 EDN1 NOS3
7 munchausen by proxy 10.5 EDN1 NOS3
8 antiphospholipid syndrome 10.5 EDN1 HTR7
9 lymphadenitis 10.4 EDN1 NOS3
10 hematocele of tunica vaginalis testis 10.4 EDN1 HTR7
11 capillary hemangioma 10.4 EDN1 NOS3
12 acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22) 10.4 EDN1 NOS3
13 joint disorders 10.4 EDN1 NOS3
14 bernard-soulier syndrome, type a2 10.4 EDN1 NOS3
15 esophageal leukoplakia 10.4 EDN1 NOS3
16 ophthalmia neonatorum 10.3 NOS3 TNNI3
17 polymicrogyria, bilateral frontoparietal 10.3 EDN1 NOS3
18 conjunctival degeneration 10.3 HTR2A HTR7
19 neurogenic bladder 10.3 HTR2A HTR7
20 allergic hypersensitivity disease 10.2 HTR2A HTR7
21 pyelonephritis 10.2 EDN1 NOS3
22 vascular cancer 10.2 HTR2A HTR7
23 preeclampsia/eclampsia 1 10.1 EDN1 NOS3
24 skull base neoplasm 10.1 EDN1 NOS3
25 hepatic infarction 10.1 EDN1 KNG1
26 rheumatic fever 10.1 EDN1 KNG1
27 mental retardation, x-linked 101 10.1 NOS3 TNNI3
28 keratosis 10.1 HTR2A HTR7
29 renal fibrosis 10.0 EDN1 NOS3 TNNI3
30 diabetic encephalopathy 10.0 EDN1 HTR2A NOS3
31 periampullary adenoma 10.0 EDN1 HTR2A NOS3
32 acute myocardial infarction 10.0
33 female breast upper-outer quadrant cancer 10.0 AHSP EDN1 TNNI3
34 peripheral artery disease 10.0 EDN1 NOS3 TNNI3
35 broad ligament malignant neoplasm 10.0 EDN1 KNG1
36 hemorrhagic disease due to alpha-1-antitrypsin pittsburgh mutation 9.9 ABCC9 TNNI3
37 acute myocarditis 9.9
38 myocarditis 9.9
39 atherosclerosis 9.9
40 bubonic plague 9.8 EDN1 NOS3
41 acute closed-angle glaucoma 9.8 ABCC9 EDN1
42 viral hepatitis 9.7 EDN1 KNG1 NOS3
43 churg-strauss syndrome 9.7
44 ischemia 9.7
45 thyroiditis 9.7
46 vasculitis 9.7
47 cardiomyopathy 9.7
48 brugada syndrome 9.7
49 subacute leukemia 9.7 EDN1 KNG1 NOS3
50 pericarditis 9.7 EDN1 KNG1 NOS3

Graphical network of the top 20 diseases related to Coronary Artery Vasospasm:



Diseases related to Coronary Artery Vasospasm

Symptoms & Phenotypes for Coronary Artery Vasospasm

UMLS symptoms related to Coronary Artery Vasospasm:


angina pectoris

MGI Mouse Phenotypes related to Coronary Artery Vasospasm:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 muscle MP:0005369 9.02 HTR2A NOS3 TNNI3 ABCC9 EDN1

Drugs & Therapeutics for Coronary Artery Vasospasm

Drugs for Coronary Artery Vasospasm (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 125)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Simvastatin Approved Phase 4 79902-63-9 54454
2
Losartan Approved Phase 4 114798-26-4 3961
3
Spironolactone Approved Phase 4,Phase 3 1952-01-7, 52-01-7 5833
4
Hydrochlorothiazide Approved, Vet_approved Phase 4 58-93-5 3639
5
Amlodipine Approved Phase 4 88150-42-9 2162
6
Bisoprolol Approved Phase 4 66722-44-9 2405
7
Doxazosin Approved Phase 4 74191-85-8 3157
8
Miconazole Approved, Investigational, Vet_approved Phase 4 22916-47-8 4189
9
Everolimus Approved Phase 4 159351-69-6 6442177
10
Sirolimus Approved, Investigational Phase 4 53123-88-9 5284616 6436030 46835353
11
Carvedilol Approved, Investigational Phase 4 72956-09-3 2585
12
Oxytocin Approved, Vet_approved Phase 4 50-56-6 439302 53477758
13
Aspirin Approved, Vet_approved Phase 4 50-78-2 2244
14
Furosemide Approved, Vet_approved Phase 4 54-31-9 3440
15
Prazosin Approved Phase 4 19216-56-9 4893
16
Ramipril Approved Phase 4 87333-19-5 5362129
17
Indapamide Approved Phase 4 26807-65-8 3702
18
Irbesartan Approved, Investigational Phase 4 138402-11-6 3749
19
Amiloride Approved Phase 4 2016-88-8, 2609-46-3 16231
20
Rosiglitazone Approved, Investigational Phase 4 122320-73-4 77999
21
Metformin Approved Phase 4 657-24-9 14219 4091
22
Clopidogrel Approved, Nutraceutical Phase 4,Phase 3 120202-66-6, 113665-84-2 60606
23
Vitamin C Approved, Nutraceutical Phase 4 50-81-7 5785 54670067
24 Tocopherol Approved, Nutraceutical Phase 4
25
Vitamin E Approved, Nutraceutical, Vet_approved Phase 4 59-02-9 14985
26
Sarpogrelate Investigational Phase 4 125926-17-2 5160
27
Angiotensin II Investigational Phase 4 68521-88-0, 4474-91-3, 11128-99-7 172198 65143
28
Rilmenidine Investigational Phase 4 54187-04-1
29 Atorvastatin Calcium Phase 4,Phase 3 134523-03-8
30
Serotonin Phase 4 50-67-9 5202
31 diuretics Phase 4,Phase 3,Early Phase 1
32 Fibrinolytic Agents Phase 4,Phase 3
33 Adrenergic Agents Phase 4,Early Phase 1
34 Adrenergic alpha-1 Receptor Antagonists Phase 4
35 Adrenergic alpha-Antagonists Phase 4
36 Mineralocorticoid Receptor Antagonists Phase 4,Phase 3
37 Mineralocorticoids Phase 4,Phase 3
38 Adrenergic Antagonists Phase 4,Early Phase 1
39 Adrenergic beta-1 Receptor Antagonists Phase 4
40 Adrenergic beta-Antagonists Phase 4,Early Phase 1
41 Serotonin Agents Phase 4
42 Serotonin Antagonists Phase 4
43 Natriuretic Agents Phase 4,Phase 3,Early Phase 1
44 Sodium Chloride Symporter Inhibitors Phase 4,Early Phase 1
45 Sympatholytics Phase 4
46 Neurotransmitter Agents Phase 4,Phase 3,Early Phase 1
47 Hormone Antagonists Phase 4,Phase 3
48 Hormones Phase 4,Phase 3
49 Diuretics, Potassium Sparing Phase 4,Phase 3
50 Angiotensin II Type 1 Receptor Blockers Phase 4

Interventional clinical trials:

(show top 50) (show all 67)

id Name Status NCT ID Phase Drugs
1 The Effect of Sarpogrelate and High Dose Statin on the Reduction of Coronary Spasm Unknown status NCT01674686 Phase 4 Sarpogrelate;Atorvastatin
2 Optimum Treatment for Drug-Resistant Hypertension Unknown status NCT02369081 Phase 4 Spironolactone;Bisoprolol;Doxazosin;Placebo
3 Monotherapy Versus Dual Therapy for Initial Treatment for Hypertension Unknown status NCT00994617 Phase 4 Losartan and hydrochlorothiazide;Hydrochlorothiazide switched over with Losartan at 8 weeks
4 Assessment of Stent Strut Coverage and Endothelial Function After Drug-Eluting Stents Unknown status NCT01073111 Phase 4
5 Cardiac Effects of Oxytocin Administrated During Cesarean Section, Signs of Myocardial Ischemia Completed NCT00777166 Phase 4 oxytocin;oxytocin
6 Efficacy of Spironolactone in Cameroonian Diabetic Patients With Resistant Hypertension Completed NCT02426099 Phase 4 Low dose spironolactone
7 Carvedilol Post-intervention Long-term Administration in Large-scale Trial Completed NCT01155635 Phase 4 Carvedilol;No Carvedilol
8 ANti-Oxidant in Variant Angina (ANOVA) Trial Recruiting NCT03228238 Phase 4 Vitamin C and Vitamin E;Statin;Standard medication for variant angina
9 Sequential Nephron Blockade vs. Dual Blockade Renin-angiotensin System + Bisoprolol in Resistant Arterial Hypertension Recruiting NCT02832973 Phase 4 Spironolactone;Furosemide,;Amiloride;Ramipril;Bisoprolol
10 Renal Artery Stenting in Patients With Documented Resistant Hypertension and Atherosclerotic Renal Artery Stenosis (ANDORRA) Recruiting NCT02539810 Phase 4 Anti hypertensive, statin and antiplatelet medication.
11 Renal Denervation in Hypertension Active, not recruiting NCT01570777 Phase 4
12 Rosiglitazone and Metformin: Outcomes Trial in Nondiabetic Patients With Stable Coronary Syndromes (Romance) Pilot Study Terminated NCT00343395 Phase 4 AVANDAMET
13 Clopidogrel Versus Adenosin in Non Urgent Percutaneous Coronary Intervention (PCI) Unknown status NCT00751491 Phase 3 Adenosin;Clopidogrel
14 Continued Safety and Performance of the TIVUS System Unknown status NCT01835535 Phase 2, Phase 3
15 Lipoprotein-associated Phospholipase A2 (Lp-PLA2) Progenitor Cells and Coronary Atherosclerosis in Humans Completed NCT01067339 Phase 3 darapladib;placebo
16 Rosuvastatin in Preventing Myonecrosis in Elective Percutaneous Coronary Interventions (PCIs) Completed NCT01007279 Phase 3 ROSUVASTATIN
17 ROsuvastatin Pretreatment to Reduce MyocArdial Periprocedural Necrosis:Comparison With Atorvastatin Reloading Completed NCT01228227 Phase 3 ATORVASTATIN 80 mg;ROSUVASTATIN 40 mg
18 The Effect of Spironolactone on Blood Pressure in Type-2 Diabetics With Resistant Hypertension Completed NCT01062763 Phase 3 spironolactone;placebo
19 Therapeutic Effect of Sildenafil in Patients With Coronary Vasospasm Withdrawn NCT00454714 Phase 3 single dose Sildenafil;Single dose placebo
20 Rapid Renal Sympathetic Denervation for Resistant Hypertension Completed NCT01520506 Phase 2
21 Addition of Homeopathy in Patients With Resistant Arterial Hypertension Completed NCT02124473 Phase 2
22 Combined Treatment of Resistant Hypertension and Atrial Fibrillation Completed NCT01117025 Phase 2
23 Remote Ischaemic Conditioning and Coronary Endothelial Function (RIC-COR) Completed NCT02666235 Phase 2
24 Chemical Renal Ethanol Sympatholysis Under CT Guidance Use for the Control of Therapy-Resistant Hypertension Recruiting NCT02653222 Phase 2
25 Distal Renal Denervation Active, not recruiting NCT02667912 Phase 1, Phase 2
26 Effect of Renal Sympathetic Denervation on Resistant Hypertension and Cardiovascular Hemodynamic in Comparison to Intensive Medical Therapy Utilizing Impedance Cardiography Active, not recruiting NCT01673516 Phase 2
27 Safety and Efficacy Study of Extracorporeal Shockwave Therapy in the Treatment of Patients With Resistant Hypertension Unknown status NCT02042066 Phase 1
28 The Use of Ambulatory Blood Pressure Monitors to Assess Angiotensin Converting Enzyme Inhibitors Recruiting NCT02623036 Phase 1 Equivalent dose enalapril;Equivalent dose lisinopril
29 Blood Markers for Inflammation and Coronary Artery Vasoreactivity Testing in Patients With Chest Pain and Normal Coronary Arteries Unknown status NCT01162824 Acetylcholine;Adenosine
30 Panic Disorder and Cardiac Risk Unknown status NCT00168506 SSRI;CBT;CBT/SSRI
31 How to Test Success of a Renal Denervation Unknown status NCT02559882
32 Effect Baroreflex Activation Therapy on the Carotid Body Unknown status NCT02210923
33 Medication Adherence and "True" Resistance in Patients With Resistant Hypertension Unknown status NCT02128386
34 Resistant Hypertension and Physical Activity Performed in a Heated Pool Unknown status NCT01863082
35 Physical Activity Program for Reducing Blood Pressure in Sleep Apnea Patients With Resistant Hypertension Unknown status NCT02057783
36 Coronary Spasm Presenting Aborted Sudden Cardiac Death, the Multicenter Registry Completed NCT02298543
37 Endothelial Dysfunction and Coronary Artery Spasm Completed NCT00619294
38 The Prevalence of Coronary Spasm in Hypertensive Patients Treated With Antihypertensive Medication Completed NCT01882790
39 The Effect of Autonomic Function on Coronary Vasomotion Completed NCT01877993
40 Effect of Glucose on Ocular Blood Flow Completed NCT00350129
41 Uric Acid Levels and Endothelial Functions Completed NCT02862522
42 Prevalence of Extracardiac Coronary Collateral Supply Via the Internal Mammary Arteries Completed NCT01676207
43 Assessment of Coronary Plaque Composition Completed NCT01581632
44 Lp-PLA2 and Coronary Atherosclerosis in Humans Completed NCT01557088
45 "Reversibility of Cardiovascular Injury With CPAP Use: Mechanisms Involved" Completed NCT01317329
46 Full Length Versus Proximal Renal Arteries Ablation Completed NCT01848275
47 Renal Sympathetic Denervation and Potential Effects on Glucose Metabolism and Cardiovascular Risk-Factors Completed NCT01630928
48 Causal Inference Research of Resistant Hypertension Treatment With Chinese Approach in a Cohort Study Completed NCT01904695 Early Phase 1 Herbs;Antihypertensive drugs
49 Reintervention-study After Previous Renal Denervation in Non-responding Patients With Severe Hypertension Completed NCT01834118
50 Autonomic Dysfunction in Resistant Hypertension Completed NCT01833429

Search NIH Clinical Center for Coronary Artery Vasospasm

Cochrane evidence based reviews: coronary vasospasm

Genetic Tests for Coronary Artery Vasospasm

Genetic tests related to Coronary Artery Vasospasm:

id Genetic test Affiliating Genes
1 Coronary Artery Spasm 29

Anatomical Context for Coronary Artery Vasospasm

MalaCards organs/tissues related to Coronary Artery Vasospasm:

39
Endothelial, Testes, Bone, Heart, Brain, Thyroid

Publications for Coronary Artery Vasospasm

Articles related to Coronary Artery Vasospasm:

(show all 49)
id Title Authors Year
1
Case series of patients treated with the oral fluoropyrimidine S-1 after capecitabine-induced coronary artery vasospasm. ( 28623776 )
2017
2
Coronary-Artery Vasospasm. ( 28636863 )
2017
3
Outcomes of Brugada Syndrome Patients with Coronary Artery Vasospasm. ( 28090040 )
2017
4
Eosinophilia-Associated Coronary Artery Vasospasm in Patients with Aspirin-Exacerbated Respiratory Disease. ( 27396680 )
2016
5
Capecitabine-induced coronary artery vasospasm in a patient who previously experienced a similar episode with fluorouracil therapy. ( 26875134 )
2016
6
IMAGES IN CLINICAL MEDICINE. Cocaine-Induced Coronary-Artery Vasospasm. ( 26840152 )
2016
7
Feasible induction of coronary artery vasospasm occurred during cardiac catheterization in a microminipig. ( 26806564 )
2016
8
Life Threatening Complication of Self-made Remedy for Controlling High Blood Pressure-Coronary Artery Vasospasm Associated with Iatrogenic Thyrotoxicosis. ( 27826349 )
2016
9
Coronary artery vasospasm during catheter cryoablation of left ventricular summit nonsustained ventricular tachycardia. ( 28491744 )
2016
10
Scombroid fish poisoning illness and coronary artery vasospasm. ( 25870660 )
2015
11
Unraveling of the Effect of Nodose Ganglion Degeneration on the Coronary Artery Vasospasm after Subarachnoid Hemorrhage; an Experimental Study. ( 26365883 )
2015
12
Organophosphate poisoning with coronary artery vasospasm confirmed by angiography. ( 25302727 )
2014
13
Amiodarone-induced destructive thyroiditis associated with coronary artery vasospasm and recurrent ventricular fibrillation. ( 24783040 )
2013
14
Patients with left main coronary artery vasospasm inadvertently undergoing coronary artery bypass grafting surgery. ( 23428222 )
2013
15
A case of caffeine-induced coronary artery vasospasm of a 17-year-old male. ( 22231478 )
2012
16
A Case of Acute Myocardial Infarction With ST-Segment Elevation in a Lead Augmented Right Vector Caused by a Left Main Coronary Artery Vasospasm. ( 22363384 )
2012
17
Capecitabine may induce coronary artery vasospasm. ( 22796820 )
2012
18
Intraoperative coronary artery vasospasm: a twist in the tale! ( 22435284 )
2011
19
Reversible ischemia on treadmill exercise in left main coronary artery vasospasm. ( 22340417 )
2011
20
Sorafenib-associated multivessel coronary artery vasospasm. ( 21584715 )
2011
21
Coronary artery vasospasm. A sudden spasm of the coronary arteries can feel like a heart attack. ( 20583353 )
2010
22
Early recognition of catheter-induced left main coronary artery vasospasm: implications for revascularization. ( 20665882 )
2010
23
Coronary artery vasospasm and acute myocarditis: a rare association. ( 21428143 )
2010
24
A case report of 5-fluorouracil-induced coronary artery vasospasm. ( 22375089 )
2010
25
Multifocal severe coronary artery vasospasm mistaken for diffuse atherosclerosis: a case report. ( 20862333 )
2010
26
Acute coronary artery vasospasm associated with misoprostol for termination of pregnancy. ( 20224253 )
2010
27
Rare manifestations of Churg-Strauss syndrome: coronary artery vasospasm, temporal artery vasculitis, and reversible monocular blindness-a case report. ( 19034601 )
2009
28
Coronary artery vasospasm causing ventricular fibrillation - an external loop recording. ( 19195763 )
2009
29
ST-segment elevation in lead augmented vector right may also be caused by diffuse left main coronary artery vasospasm without fixed stenosis. ( 18404728 )
2008
30
Coronary artery vasospasm during awake deep brain stimulation surgery. ( 18534972 )
2008
31
Eosinophilia and coronary artery vasospasm. ( 18718813 )
2008
32
Coronary artery vasospasm or true transient left ventricular apical ballooning? Differentiation by nuclear imaging. ( 18674728 )
2008
33
Coronary artery vasospasm with iron sucrose. ( 17327282 )
2007
34
Coronary artery vasospasm during dobutamine stress echocardiography. ( 15891761 )
2005
35
Coronary artery vasospasm causing acute myocardial infarction in a heart transplant recipient. ( 15737767 )
2005
36
5-flurouracil induced coronary artery vasospasm. ( 15020524 )
2004
37
Secondary coronary artery vasospasm promotes cardiomyopathy progression. ( 14982859 )
2004
38
Episodic coronary artery vasospasm and hypertension develop in the absence of Sur2 K(ATP) channels. ( 12122112 )
2002
39
Acute myocardial infarction associated with myocardial bridge and coronary artery vasospasm. ( 12469991 )
2002
40
Amine metabolism: a novel path to coronary artery vasospasm. ( 11543647 )
2001
41
Use of exercise myocardial perfusion imaging to guide and assess the effectiveness of medical therapy in coronary artery vasospasm. ( 9588677 )
1998
42
Ephedrine-induced coronary artery vasospasm in a patient with prior cocaine use. ( 9085987 )
1997
43
Positron emission tomography with oxygen-15 of stunned myocardium caused by coronary artery vasospasm after recovery. ( 7888266 )
1995
44
Coronary artery vasospasm complicating acute myocarditis. A rare association. ( 3176473 )
1988
45
Observations on increased susceptibility to coronary artery vasospasm during beta blockade. ( 2886035 )
1987
46
The importance of excluding coronary artery vasospasm before percutaneous transluminal coronary angioplasty. A case report. ( 2946085 )
1986
47
Coronary artery vasospasm during treatment with intravenous nitroglycerin. ( 3930071 )
1985
48
Coronary artery vasospasm and emotional stress: a hypothetical link to atherosclerosis. ( 6270513 )
1981
49
Coronary artery vasospasm: the likely immediated cause of acute myocardial infarction. ( 380605 )
1979

Variations for Coronary Artery Vasospasm

Expression for Coronary Artery Vasospasm

Search GEO for disease gene expression data for Coronary Artery Vasospasm.

Pathways for Coronary Artery Vasospasm

Pathways related to Coronary Artery Vasospasm according to GeneCards Suite gene sharing:

id Super pathways Score Top Affiliating Genes
1
Show member pathways
11.07 HTR2A HTR7 NOS3
2 10.99 EDN1 NOS3
3 10.69 EDN1 NOS3
4 10.4 HTR2A HTR7

GO Terms for Coronary Artery Vasospasm

Cellular components related to Coronary Artery Vasospasm according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 caveola GO:0005901 8.96 HTR2A NOS3
2 sarcomere GO:0030017 8.62 ABCC9 TNNI3

Biological processes related to Coronary Artery Vasospasm according to GeneCards Suite gene sharing:

(show all 15)
id Name GO ID Score Top Affiliating Genes
1 response to drug GO:0042493 9.67 ABCC9 EDN1 HTR2A
2 regulation of blood pressure GO:0008217 9.55 EDN1 NOS3
3 positive regulation of MAP kinase activity GO:0043406 9.54 EDN1 HTR2A
4 positive regulation of cytosolic calcium ion concentration GO:0007204 9.54 EDN1 HTR2A KNG1
5 regulation of cardiac conduction GO:1903779 9.52 ABCC9 TNNI3
6 sensory perception of pain GO:0019233 9.51 EDN1 HTR2A
7 phosphatidylinositol 3-kinase signaling GO:0014065 9.48 EDN1 HTR2A
8 vasodilation GO:0042311 9.46 KNG1 NOS3
9 smooth muscle contraction GO:0006939 9.43 HTR2A HTR7
10 vasoconstriction GO:0042310 9.4 EDN1 HTR7
11 negative regulation of blood coagulation GO:0030195 9.32 EDN1 KNG1
12 negative regulation of potassium ion transport GO:0043267 9.26 HTR2A NOS3
13 artery smooth muscle contraction GO:0014824 9.16 EDN1 HTR2A
14 regulation of systemic arterial blood pressure by endothelin GO:0003100 8.96 EDN1 NOS3
15 regulation of blood vessel size GO:0050880 8.8 EDN1 KNG1 NOS3

Molecular functions related to Coronary Artery Vasospasm according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 neurotransmitter receptor activity GO:0030594 9.16 HTR2A HTR7
2 G-protein coupled serotonin receptor activity GO:0004993 8.96 HTR2A HTR7
3 serotonin binding GO:0051378 8.62 HTR2A HTR7

Sources for Coronary Artery Vasospasm

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....